Review





Similar Products

99
TaKaRa bamhi recognition site
Bamhi Recognition Site, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bamhi recognition site/product/TaKaRa
Average 99 stars, based on 1 article reviews
bamhi recognition site - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

97
Miltenyi Biotec annexin v fitc apoptosis recognition kit
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Annexin V Fitc Apoptosis Recognition Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annexin v fitc apoptosis recognition kit/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
annexin v fitc apoptosis recognition kit - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

86
Mendeley Ltd data bangla meder bangla medical entity recognition dataset
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Data Bangla Meder Bangla Medical Entity Recognition Dataset, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/data bangla meder bangla medical entity recognition dataset/product/Mendeley Ltd
Average 86 stars, based on 1 article reviews
data bangla meder bangla medical entity recognition dataset - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Northern Digital optical recognition system
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Optical Recognition System, supplied by Northern Digital, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optical recognition system/product/Northern Digital
Average 86 stars, based on 1 article reviews
optical recognition system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Biotechnology Information phyre2: protein homology/analogy recognition engine 2 polyphen-2
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Phyre2: Protein Homology/Analogy Recognition Engine 2 Polyphen 2, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phyre2: protein homology/analogy recognition engine 2 polyphen-2/product/Biotechnology Information
Average 86 stars, based on 1 article reviews
phyre2: protein homology/analogy recognition engine 2 polyphen-2 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Novogene casava base recognition
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Casava Base Recognition, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/casava base recognition/product/Novogene
Average 86 stars, based on 1 article reviews
casava base recognition - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Aslan Pharmaceuticals speech recognition
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Speech Recognition, supplied by Aslan Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/speech recognition/product/Aslan Pharmaceuticals
Average 86 stars, based on 1 article reviews
speech recognition - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Kaggle Inc kaggle voice recognition
Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via <t>apoptosis</t> and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism
Kaggle Voice Recognition, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kaggle voice recognition/product/Kaggle Inc
Average 86 stars, based on 1 article reviews
kaggle voice recognition - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via apoptosis and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism

Journal: BMC Pharmacology & Toxicology

Article Title: Computational-experimental repurposing reveals synergistic sorafenib/hydroxychloroquine response in KRAS-mutant breast cancer

doi: 10.1186/s40360-026-01122-2

Figure Lengend Snippet: Schematic representation of the integrated computational and experimental workflow. The study design comprises two complementary branches. The computational branch (left) includes protein preparation, ligand parameterization, 100 ns MD simulation, trajectory analysis (RMSD, RMSF, Rg, H-bonds, contact frequency), and MM/GBSA binding free energy calculation. The experimental branch (right) comprises cell culture, MTT cytotoxicity assays for single drugs, combination ratio testing (SN: HQ = 1:1, 1:2, 2:1), CI/DRI analysis, and mechanistic validation via apoptosis and cell cycle assays. The integration of both approaches provides a comprehensive understanding of the synergistic mechanism

Article Snippet: The Annexin V-FITC apoptosis recognition kit (Miltenyi Biotec) was conducted to assess apoptosis.

Techniques: Binding Assay, Cell Culture, Biomarker Discovery

Apoptosis investigation via flow cytometry. Cells were stained with Annexin V-FITC and propidium iodide (PI) to distinguish viable (lower left), early apoptotic (lower right), late apoptotic (upper right), and necrotic (upper left) populations. Representative dot plots are shown for: ( a ) untreated control; ( b ) hydroxychloroquine (23.6 µM); ( c ) sorafenib (9.4 µM); and ( d ) their combination (5 µM HCQ + 1 µM Sorafenib). ( e ) Quantitative summary of cell populations across treatment groups. Hydroxychloroquine treatment significantly reduced viable cells (from 88.09% to 8.52%, **** p < 0.000001) and significantly increased early apoptosis (2.43% to 5.54%, **** p < 0.000001), late apoptosis (1.75% to 34.87%, **** p < 0.000001), and necrosis (2.23% to 49.40%, **** p < 0.000001) compared to control

Journal: BMC Pharmacology & Toxicology

Article Title: Computational-experimental repurposing reveals synergistic sorafenib/hydroxychloroquine response in KRAS-mutant breast cancer

doi: 10.1186/s40360-026-01122-2

Figure Lengend Snippet: Apoptosis investigation via flow cytometry. Cells were stained with Annexin V-FITC and propidium iodide (PI) to distinguish viable (lower left), early apoptotic (lower right), late apoptotic (upper right), and necrotic (upper left) populations. Representative dot plots are shown for: ( a ) untreated control; ( b ) hydroxychloroquine (23.6 µM); ( c ) sorafenib (9.4 µM); and ( d ) their combination (5 µM HCQ + 1 µM Sorafenib). ( e ) Quantitative summary of cell populations across treatment groups. Hydroxychloroquine treatment significantly reduced viable cells (from 88.09% to 8.52%, **** p < 0.000001) and significantly increased early apoptosis (2.43% to 5.54%, **** p < 0.000001), late apoptosis (1.75% to 34.87%, **** p < 0.000001), and necrosis (2.23% to 49.40%, **** p < 0.000001) compared to control

Article Snippet: The Annexin V-FITC apoptosis recognition kit (Miltenyi Biotec) was conducted to assess apoptosis.

Techniques: Flow Cytometry, Staining, Control